- SEK7.68bn
- SEK12.43bn
- SEK11.00bn
Brief: Arjo Appoints Daniel Fäldt New CFO
Brief: Arjo Starts Randomized Controlled Trial For Wound Care Treatment
Brief: Arjo Q4 Adjusted EBITDA Increases 25.4% TO SEK 513 Mln
Brief: Daniel Fäldt Appointed CFO At Arjo
Brief: Arjo: Jonas Lindqvist To Leave CFO Position
Brief: Arjo Q3 Adjusted EBITDA Increased By 26.6% To SEK 381 Mln
Brief: Arjo Q2 EBITDA Up At SEK 421 Million
Brief: Arjo Acquires Equity Stake In Atlas Lift Tech
Brief: Arjo Q1 EBITDA Rises To SEK 413 Mln
Swedish stocks: seen opening higher, Latour divests Loomis stake
Brief: Arjo Confirms 2018-2020 Financial Targets And 2019 Outlook
Brief: Arjo Q4 EBITDA Rises To SEK 348 Mln
Brief: Arjo Q3 Adjusted EBITDA Up At SEK 301 Million
Brief: Arjo To Divest Low-Spec Medical Beds Business
Brief: Arjo Q2 Adjusted EBITDA Up At SEK 313 Million
Brief: Arjo Acquires Renu Medical
Brief: Arjo Enters Into Exclusive Research And Development Partnership With Next Step Dynamics
Brief: Arjo Q1 Adjusted EBITDA At SEK 289 Million
Brief: Arjo Establishes SEK 2.5 Bln Commercial Paper Programme